A comparison of four leukapheresis methods to harvest an optimal dose of <scp>CD34</scp> + cells: A single center experience-Reference-Cited by-同舟云学术

A comparison of four leukapheresis methods to harvest an optimal dose of CD34 + cells: A single center experience

Published:2022-09-12 Issue:6 Volume:109 Page:711-718
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:European J of Haematology

Author:

Lin Yuankai¹^ORCID,Park Youngmin²,Khanal Amit¹,Campbell‐Lee Sally³,Liu Li³⁴,Chen Zhengjia³⁴,Patel Pritesh¹,Vidanovic Vladimir³,Sweiss Karen⁵,Irene Grace²,Peace David¹,Rondelli Damiano¹,Mahmud Nadim¹²^ORCID

Affiliation:

1. Division of Hematology and Oncology University of Illinois College of Medicine Chicago Illinois USA

2. Clinical Stem Cell Laboratory UI Health Chicago Illinois USA

3. Division of Epidemiology and Biostatistics University of Illinois Chicago Illinois USA

4. Biorstatistics Shared Resource Center University of Illinois Cancer Center Chicago Illinois USA

5. Department of Pharmacy Practice College of Pharmacy, University of Illinois Chicago Illinois USA

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13856

Reference18 articles.

1. Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma

2. High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.

3. Factors that influence collection and engraftment of autologous peripheral-blood stem cells.

4. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients

5. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting the CD34 content of mobilized peripheral blood leukapheresis products: single institution experience over 20 years;Cytotherapy;2024-02